VOYA Investment Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Buy |
|
|||||
|
2025
Q1 | $310K | Sell |
|
|||||
|
2024
Q4 | $263K | Sell |
|
|||||
|
2024
Q3 | $660K | Buy |
|
|||||
|
2024
Q2 | $1.06M | Sell |
|
|||||
|
2024
Q1 | $1.08M | Buy |
|
|||||
|
2023
Q4 | $1.14M | Buy |
|
|||||
|
2023
Q3 | $804K | Buy |
|
|||||
|
2023
Q2 | $1.04M | Buy |
|
|||||
|
2023
Q1 | $1.03M | Sell |
|
|||||
|
2022
Q4 | $8.21M | Sell |
|
|||||
|
2022
Q3 | $17.9M | Buy |
|
|||||
|
2022
Q2 | $5.68M | Sell |
|
|||||
|
2022
Q1 | $25.4M | Buy |
|
|||||
|
2021
Q4 | $1.72M | Sell |
|
|||||
|
2021
Q3 | $1.71M | Sell |
|
|||||
|
2021
Q2 | $1.86M | Sell |
|
|||||
|
2021
Q1 | $2.26M | Buy |
|
|||||
|
2020
Q4 | $1.9M | Buy |
|
|||||
|
2020
Q3 | $1.48M | Sell |
|
|||||
|
2020
Q2 | $1.3M | Sell |
|
|||||
|
2020
Q1 | $1.03M | Buy |
|
|||||
|
2019
Q4 | $893K | Buy |
|
|||||
|
2019
Q3 | $614K | Hold |
|
|||||
|
2019
Q2 | $701K | Sell |
|
|||||
|
2019
Q1 | $622K | Sell |
|
|||||
|
2018
Q4 | $719K | Buy |
|
|||||
|
2018
Q3 | $796K | Sell |
|
|||||
|
2018
Q2 | $524K | Sell |
|
|||||
|
2018
Q1 | $547K | Sell |
|
|||||
|
2017
Q4 | $26.9M | Sell |
|
|||||
|
2017
Q3 | $22.2M | Buy |
|
|||||
|
2017
Q2 | $22.2M | Buy |
|
|||||
|
2017
Q1 | $20.3M | Sell |
|
|||||
|
2016
Q4 | $17.4M | Buy |
|
|||||
|
2016
Q3 | $12K | Sell |
|
|||||
|
2016
Q2 | $12.3M | Buy |
|
|||||
|
2016
Q1 | $14.4M | Sell |
|
|||||
|
2015
Q4 | $24.8M | Sell |
|
|||||
|
2015
Q3 | $15.1M | Buy |
|
|||||
|
2015
Q2 | $20.5M | Buy |
|
|||||
|
2015
Q1 | $17.3M | Sell |
|
|||||
|
2014
Q4 | $25.6M | Buy |
|
|||||
|
2014
Q3 | $14.2M | Buy |
|
|||||
|
2014
Q2 | $10.5M | Buy |
|
|||||
|
2014
Q1 | $1.12M | Hold |
|
|||||
|
2013
Q4 | $918K | Hold |
|
|||||
|
2013
Q3 | $768K | Hold |
|
|||||
|
2013
Q2 | $463K | Buy |
|